Skip to Content
Merck
All Photos(3)

Key Documents

STS0212

Sigma-Aldrich

ECO BRIJ® L4

greener alternative

average Mn ~362

Synonym(s):

Brij® L4, Polyethylene glycol dodecyl ether, Polyoxyethylene (4) lauryl ether

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
(C20H42O5)n
CAS Number:
MDL number:
UNSPSC Code:
12165104
NACRES:
NA.28

description

non-ionic

Quality Level

form

semisolid (may be liquid)

mol wt

average Mn ~362

greener alternative product characteristics

Use of Renewable Feedstocks
Design for Degradation
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

impurities

≤1.0% water

refractive index

n20/D 1.451 (lit.)

mp

48 °C

acid number

≤2.0 mg KOH/g

hydroxyl value

144‑165 mg KOH/g

solubility

water: insoluble

density

0.95 g/mL at 25 °C (lit.)

HLB

9.7

greener alternative category

SMILES string

CCCCCCCCCCCCOCCOCCOCCOCCO

InChI

1S/C20H42O5/c1-2-3-4-5-6-7-8-9-10-11-13-22-15-17-24-19-20-25-18-16-23-14-12-21/h21H,2-20H2,1H3

InChI key

WPMWEFXCIYCJSA-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

ECO Brij® L4, also known as polyethylene glycol lauryl ether, is a bio-based, nonionic surfactant manufactured from naturally occurring straight-chain lauryl alcohol. This detergent, derived from natural sources, provides various functional advantages, such as detergency, emulsification, and wetting, making it suitable for a range of applications in biochemical and biological research.
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Green Chemistry. This product is a biobased surfactant and is aligned with the 7th principle of Green Chemistry "Use of Renewable Feedstocks" and the 10th principle "Design for Degradation".

Features and Benefits

  • 100 % Renewable
  • 100 % Bio-based
  • Certified to the USDA BioPreferred Program
  • Lower carbon footprint than petrochemical-based versions
  • High-purity chemical suitable for a wide variety of research applications

Physical properties

The ECO Brij series of ethoxylated fatty alcohols are non-ionic surfactants manufactured using renewable sources. ECO Brij L4 is a mixture of tetraethylene glycol alkyl ethers, primarily dodecyl (C12) ether. The alkyl ether profile of ECO Brij L4 may differ lot-to-lot due to natural variability in the lipid starting material (palm oil).

Other Notes

For additional information on our range of Biochemicals, please complete this form.

Legal Information

Brij is a registered trademark of Croda International PLC
ECO BRIJ is a registered trademark of Croda Inc.

Pictograms

Exclamation markEnvironment

Signal Word

Warning

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jacomina W van den Esschert et al.
Annals of surgery, 255(2), 311-318 (2012-01-14)
To compare the safety and hypertrophy response after portal vein embolization (PVE) using 2 absorbable and 3 permanent embolization materials. Portal vein embolization is used to increase future remnant liver volume preoperatively. Application of temporary, absorbable embolization materials could be
Otte Brosjö et al.
Acta orthopaedica, 84(5), 502-505 (2013-11-01)
Recent data suggest that percutaneous sclerotherapy is a safe alternative to surgery for treatment of aneurysmal bone cysts (ABCs). We present our experience of this method. We retrospectively analyzed data from 38 consecutive patients treated with repeated injections of polidocanol.
Stefanie Reich-Schupke et al.
VASA. Zeitschrift fur Gefasskrankheiten, 42(1), 50-55 (2013-02-07)
According to the current guidelines for sclerotherapy hypercoagulability and thrombophilia with or without deep venous thrombosis are seen as relative contraindication for this treatment. But often such patients have an indication for a sclerotherapy. Recommendations for additional anticoagulation for sclerotherapy
A Erkin et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 44(6), 593-597 (2012-11-06)
Foam sclerosants are widely used in sclerotherapy and have been accepted as more effective than the liquid form; however, there is no consensus about the most applicable and effective concentration. The aim of this study was to investigate the histopathological
Takashi Yamaki et al.
Journal of vascular surgery, 56(6), 1649-1655 (2012-05-23)
This study assessed changes in the calf muscle deoxygenated hemoglobin (HHb) level during light-intensity exercise after ultrasound-guided foam sclerotherapy (UGFS) for superficial venous insufficiency. UGFS with 1% or 3% polidocanol foam (POL-F) was used to treat unilateral great saphenous vein

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service